磁共振成像预测中线胶质瘤H3 K27M突变:系统综述与Meta分析
该系统综述与Meta分析纳入7项原始研究共593例患者中的240例胶质瘤患者,评估MRI预测中线胶质瘤H3 K27M突变的效能,汇总敏感度为0.78(95%CI 0.66-0.87)、特异度为0.85(95%CI 0.76-0.91),提示MRI对H3 K27M突变具有预测价值。
要点
- MRI预测中线胶质瘤H3 K27M突变的汇总敏感度为0.78(95%CI 0.66-0.87),特异度为0.85(95%CI 0.76-0.91)。
- 汇总阳性似然比5.07(95%CI 3.19-8.08),阴性似然比0.26(95%CI 0.16-0.42),诊断比值比19.80(95%CI 9.28-42.28)。
- 纳入研究间敏感度、阴性似然比及诊断比值比存在显著异质性。
核心结论
- Meta分析显示MRI对预测中线胶质瘤H3 K27M突变具有临床价值,汇总敏感度0.78、特异度0.85。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、Embase、ISI Web of Science及Cochrane Library截至2021年6月31日,由两名神经放射科医师完成检索;纳入7项原始研究共593例患者,其中240例胶质瘤患者纳入分析。
诊断标准与关键数值
- MRI预测H3 K27M突变的汇总敏感度0.78(95%CI 0.66-0.87)、特异度0.85(95%CI 0.76-0.91)、阳性似然比5.07(95%CI 3.19-8.08)、阴性似然比0.26(95%CI 0.16-0.42)、诊断比值比19.80(95%CI 9.28-42.28);采用分层汇总受试者工作特征(HSROC)模型计算。
临床应用与阅片要点
- 原文结论指出MRI对预测中线胶质瘤H3 K27M突变具有临床价值,汇总敏感度0.78、特异度0.85。
局限性
- 纳入研究间敏感度存在显著异质性(Q=16.83,df=7,p=0.02;I2=58.40,95%CI 25.83-90.97)。
- 纳入研究间阴性似然比存在显著异质性(Q=16.61,df=7,p=0.02;I2=57.87,95%CI 24.81-90.93)。
- 纳入研究间诊断比值比存在显著异质性(Q=14.05,df=7,p=0.05;I2=50.18,95%CI 10.06-90.31)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To summarize the predictive value of MRI for H3 K27M-mutant in midline gliomas using meta-analysis.
METHODS: Systematic electronic searches of the PubMed, Embase, ISI Web of Science, and Cochrane Library up to Jun 31, 2021, were conducted by two experienced neuroradiologists with the keywords of "MRI," "Glioma," and "H3 K27M." The hierarchical summary receiver-operating characteristic (HSROC) model was used to calculate the pooled sensitivity, specificity, positive likelihood ratio (LR +), negative likelihood ratio (LR -), and diagnostic odds ratio (DOR). Coupled forest plots were used to evaluate the heterogeneity of the included studies.
RESULTS: Of seven original studies with a total of 593 patients, 240 glioma patients were included, with 45.5-70.6% H3 K27M-mutant gliomas. Using MRI, a pooled sensitivity of 0.78 (95% CI, 0.66-0.87), specificity of 0.85 (95% CI, 0.76-0.91), LR + of 5.07 (95% CI, 3.19-8.08), LR - of 0.26 (95% CI, 0.16-0.42), and DOR of 19.80 (95% CI, 9.28-42.28) were achieved for H3 K27M-mutant prediction. Significant heterogeneity was observed among the studies in terms of sensitivity (Q = 16.83, df = 7, p = 0.02; I2 = 58.40 [95% CI, 25.83-90.97]), LR - (Q = 16.61, df = 7, p = 0.02; I2 = 57.87 [95% CI, 24.81-90.93]), and DOR (Q = 14.05, df = 7, p = 0.05; I2 = 50.18 [95% CI, 10.06-90.31]).
CONCLUSIONS: This meta-analysis demonstrated a clinical value of MRI to predict H3 K27M-mutant in midline gliomas with a pooled sensitivity of 0.78 and specificity of 0.85.
引用
- Hua, Zhuo, Duan, et al. Prediction of H3 K27M-mutant in midline gliomas by magnetic resonance imaging: a systematic review and meta-analysis. Neuroradiology. 2022. PMID: 35416485. doi:10.1007/s00234-022-02947-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。